Non-Hallucinogenic Psychedelic Compound

Japanese Pharma Company Sponsors Australian Start Up In Development Of Non-Hallucinogenic Medicines
Delix's Non-Hallucinogen Completes Safe Administration To First Clinical Trial Cohort
BetterLife's Non-Hallucinogenic LSD's Clinical Studies, Braxia's Psychedelic Treatments Continue
Delix's Non-Hallucinogen Completes Safe Administration To First Clinical Trial Cohort
BetterLife's Non-Hallucinogenic LSD's Clinical Studies, Braxia's Psychedelic Treatments Continue
Psychedelics For Treating Depression: New Research Finds Key In BDNF Receptor
MA, FL And OH Psychedelics Scientists And Educators' Latest Research And Views

Non-Hallucinogenic Psychedelic Compound Recent News

BetterLife Engages Canadian Healthcare Investment Firm, Aims For Clinical Trial Programs
BetterLife Pharma (OTCQB: BETRF), a non-hallucinogenic psychedelics biotech company, has contracted Bloom Burton Securities Inc. for strategic advisory services.
Ceruvia Lifesciences Begins Dosing Volunteers In Research On Non Hallucinogenic LSD Compound
Clinical-stage psychedelics biopharma company Ceruvia Lifesciences has dosed the first participant in its Phase 1 trial on NYPRG-101, aka BOL-148, an LSD non-hallucinogenic analog with a clinical and experimental administration history that dates back to the 1950s.
Psychedelics & Role Of Memory In Healing Process, New Trial Led By Univ. Of Wisconsin
The University of Wisconsin-Madison Transdisciplinary Center for Research in Psychoactive Substances (TCRPS) was created to foster education and research on the field of medical applications of psychedelics, and one of them is specifically studying if remembering the psychedelic-induced hallucinations is a fundamental part of these substances' therapeutic effects.
Psychedelics Companies And IPs: An Extended Patent Application To Protect Multiple LSD Derivatives
In parallel with working towards discovering and advancing therapeutic psychedelics, biopharma companies are continuously protecting their findings.
This Company Just Created 3 Brand New Psychedelics—Without The Hallucinogenic Side Effects
Mindset Pharma Inc. (OTCQB: MSSTF), a company producing psychedelic and non-psychedelic drugs for mental health conditions has recently identified three additional families of highly novel, non-tryptamine psychedelic compounds.